Search research articles
Contact Us
Filters
Showing results (311-320 of 348) with videos related to
Page
of 35
Sort By:
Epilepsia
|
January 12, 2011
The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission
Ingmar Blümcke, Maria Thom, Eleonora Aronica, et al.
Brain : a Journal of Neurology
|
October 21, 2017
Clinical, pathological and functional characterization of riboflavin-responsive neuropathy
Andreea Manole, Zane Jaunmuktane, Iain Hargreaves, et al.
Nature Genetics
|
February 25, 2025
Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1
Thomas R W Oliver, Andrew R J Lawson, Henry Lee-Six, et al.
Neuro-Oncology
|
July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse
Stacey Richardson, Rebecca M Hill, Christopher Kui, et al.
NPJ Precision Oncology
|
March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature
Philipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Cancer Cell
|
May 16, 2018
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
Alan Mackay, Anna Burford, Valeria Molinari, et al.
Neuro-Oncology
|
November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Philipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology
|
December 1, 2021
Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles
Michael Zhang, Edward Wang, Derek Yecies, et al.
Epilepsia
|
May 31, 2012
Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias
Roland Coras, Onno J de Boer, Dawna Armstrong, et al.
Cancer Cell
|
December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease
Rebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 348) with videos related to
Sort By:
Page
of 35
Epilepsia
|
January 12, 2011
The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission
Ingmar Blümcke, Maria Thom, Eleonora Aronica, et al.
Brain : a Journal of Neurology
|
October 21, 2017
Clinical, pathological and functional characterization of riboflavin-responsive neuropathy
Andreea Manole, Zane Jaunmuktane, Iain Hargreaves, et al.
Nature Genetics
|
February 25, 2025
Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1
Thomas R W Oliver, Andrew R J Lawson, Henry Lee-Six, et al.
Neuro-Oncology
|
July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse
Stacey Richardson, Rebecca M Hill, Christopher Kui, et al.
NPJ Precision Oncology
|
March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature
Philipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Cancer Cell
|
May 16, 2018
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
Alan Mackay, Anna Burford, Valeria Molinari, et al.
Neuro-Oncology
|
November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Philipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology
|
December 1, 2021
Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles
Michael Zhang, Edward Wang, Derek Yecies, et al.
Epilepsia
|
May 31, 2012
Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias
Roland Coras, Onno J de Boer, Dawna Armstrong, et al.
Cancer Cell
|
December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease
Rebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
Page
of 35